Brand name authorized in: Hong Kong
The drug ADARAN contains a combination of these active pharmaceutical ingredients (APIs):
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.
This drug has been assigned below unique identifiers within the countries it is being marketed: